Literature DB >> 24696115

Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.

Pablo Sanchez-Salcedo1, Miguel Divo2, Ciro Casanova3, Victor Pinto-Plata2, Juan P de-Torres1, Claudia Cote4, Carlos Cabrera5, Jorge Zagaceta1, Roberto Rodriguez-Roisin6, Javier J Zulueta1, Jose Maria Marin7, Bartolome Celli8.   

Abstract

Chronic obstructive pulmonary disease (COPD), although frequent in older individuals, can also occur at younger age; this latter population has not been well described. We reviewed the functional progression of 1708 patients with COPD attending pulmonary clinics. Those with three or more annual spirometries were divided into those who, at enrolment, were ≤ 55 (n = 103) or ≥ 65 (n = 463) years of age (younger and older COPD, respectively). Baseline and annual changes in lung function (forced expiratory volume in 1 s (FEV1)) and BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity) score were recorded and compared between both groups. Severity distribution by Global Initiative for Chronic Obstructive Lung Disease and BODE scores were similar in both groups, except for mild obstruction, which was higher in the younger group. Mean FEV1 decline was 38.8 and 40.6 mL · year(-1), while BODE scores increased 0.19 and 0.23 units per year, for younger and older COPD, respectively. Both groups had similar proportion of FEV1 rapid decliners (42% and 46%, respectively). The severity distribution and progression of disease in younger patients with COPD is similar to that of patients of older age. This observation suggests that younger individuals presenting with COPD develop the disease from an already compromised pulmonary and systemic status, complementing the model of steeper decline of lung function proposed by Fletcher and Peto. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24696115     DOI: 10.1183/09031936.00208613

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  The Course of Lung Function in Middle-aged Heavy Smokers: Incidence and Time to Early Onset of Chronic Obstructive Pulmonary Disease.

Authors:  Hans Petersen; Akshay Sood; Francesca Polverino; Caroline A Owen; Victor Pinto-Plata; Bartolomé R Celli; Yohannes Tesfaigzi
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 21.405

2.  Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.

Authors:  Yunus Çolak; Shoaib Afzal; Børge G Nordestgaard; Jørgen Vestbo; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

3.  COPD Overdiagnosis, Underdiagnosis, and Treatment.

Authors:  Cristine E Berry; Barbara P Yawn
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-15

4.  At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.

Authors:  Fernando J Martinez; MeiLan K Han; James P Allinson; R Graham Barr; Richard C Boucher; Peter M A Calverley; Bartolome R Celli; Stephanie A Christenson; Ronald G Crystal; Malin Fagerås; Christine M Freeman; Lars Groenke; Eric A Hoffman; Mehmet Kesimer; Kostantinos Kostikas; Robert Paine; Shahin Rafii; Stephen I Rennard; Leopoldo N Segal; Renat Shaykhiev; Christopher Stevenson; Ruth Tal-Singer; Jørgen Vestbo; Prescott G Woodruff; Jeffrey L Curtis; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 5.  Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.

Authors:  Daniel Hoesterey; Nilakash Das; Wim Janssens; Russell G Buhr; Fernando J Martinez; Christopher B Cooper; Donald P Tashkin; Igor Barjaktarevic
Journal:  Respir Med       Date:  2019-08-09       Impact factor: 3.415

Review 6.  Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.

Authors:  Fernando J Martinez; Alvar Agusti; Bartolome R Celli; MeiLan K Han; James P Allinson; Surya P Bhatt; Peter Calverley; Sanjay H Chotirmall; Badrul Chowdhury; Patrick Darken; Carla A Da Silva; Gavin Donaldson; Paul Dorinsky; Mark Dransfield; Rosa Faner; David M Halpin; Paul Jones; Jerry A Krishnan; Nicholas Locantore; Fernando D Martinez; Hana Mullerova; David Price; Klaus F Rabe; Colin Reisner; Dave Singh; Jørgen Vestbo; Claus F Vogelmeier; Robert A Wise; Ruth Tal-Singer; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2022-02-01       Impact factor: 21.405

7.  Is COPD a Progressive Disease? A Long Term Bode Cohort Observation.

Authors:  Juan P de-Torres; Jose M Marín; Víctor Pinto-Plata; Miguel Divo; Pablo Sanchez-Salcedo; Jorge Zagaceta; Javier J Zulueta; Juan Berto; Carlos Cabrera; Bartolome R Celli; Ciro Casanova
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

Review 8.  Strategies for Management of the Early Chronic Obstructive Lung Disease.

Authors:  Jung Yeon Lee; Chin Kook Rhee; Ki Suck Jung; Kwang Ha Yoo
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-07-01

Review 9.  Palliative care in COPD: an unmet area for quality improvement.

Authors:  Julia H Vermylen; Eytan Szmuilowicz; Ravi Kalhan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-08-06

10.  Age-related annual decline of lung function in patients with COPD.

Authors:  Soo Jung Kim; Jinwoo Lee; Young Sik Park; Chang-Hoon Lee; Ho Il Yoon; Sang-Min Lee; Jae-Joon Yim; Young Whan Kim; Sung Koo Han; Chul-Gyu Yoo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.